Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures

NCT06713798 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT06713798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06713798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Phase 2
Overall status
Withdrawn
Start date
January 30, 2025
Completion date
September 15, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced lung cancer, cbnpc cancer, metastatic cancer lung